Dear all,
Registration to SCANDEM 2026, taking place June 9–12, 2026 in Oulu, is now OPEN!
This meeting offers an excellent opportunity for researchers and students to:
*
Discover the latest developments in microscopy and imaging
*
Attend inspiring talks by leading experts
*
Connect with industry representatives at the company exhibition
*
Share your own research through poster sessions and selected talks
[cid:1fefc8b0-9aa9-4988-851d-7882ee411f55]
Mark your calendars and visit the SCANDEM 2026<http://ssl.eventilla.com/scandem2026> website for detailed information.
Important dates:
*
Registration : early bird until April 15
*
Abstract submission: by March 31 (for posters and selected talks)
We look forward to welcoming you to SCANDEM2026 for an exciting event!
On behalf of the SCANDEM 2026 Organizing Committee,
Ilkka Miinalainen
Hi all,
After a very long and frustrating wait, our new TEM (JEM-120i) is available for use. I have put the instrument status as "online" and you can use iLab to reserve it. Instrument is very user friendly and I´ll be happy to train you to use it. Apologies for the delay.
Best regards,
Ilkka
Ilkka Miinalainen, Ph.D.
Docent in Biological Electron Microscopy
Head of Biocenter Oulu Electron Microscopy Core Facility
Mailing address: P.O Box 5000, FIN-90014, University of Oulu
Street address: Aapistie 5A, FIN-90220 Oulu
Tel. int. 486145, ext. 0294 486145
Tel. +358 294 486 145
mailto:ilkka.miinalainen@oulu.fi
www.oulu.fi/biocenter/em<http://www.oulu.fi/biocenter/em>
Please be kindly invited to join us to this webinar.
MBD Co., Ltd. from South Korea (Medical & Bio Decision) will present on Thursday, January 15, 9 am its solution for an automated, cell-level 3D organoid-based high-throughput screening (HTS) process for efficacy and toxicity testing.
The company has developed a new 3D cell culture technology that enables the cultivation of organoids and the automated, high-throughput analysis and evaluation of drug or anticancer compound efficacy and toxicity. This platform addresses the key challenges in conventional organoid research — reproducibility, standardization, and throughput — significantly improving the efficiency and accuracy of preclinical and clinical studies for new drug development.
Based on this platform, MBD currently collaborates with over 30 university hospitals in Korea as well as several research institutes in Europe, offering personalized chemotherapy efficacy testing services.
MBD would be interested in a collaboration with University of Oulu research groups. Different kinds of funding possibilites, e.g. EU funding and perhaps funding from the Academy of Finland could be considered for a common research project.
Dr. Ulla Lenkkeri-Schütz with SkyinQ Team from Luxembourg will be hosting the event.
Join with Google Meet<https://meet.google.com/pff-hhgy-rdk?hs=224>
Meeting link
meet.google.com/pff-hhgy-rdk<https://meet.google.com/pff-hhgy-rdk?hs=224>
Join by phone
(LU) +352 27 87 09 45
PIN: 316492054
More phone numbers<https://tel.meet/pff-hhgy-rdk?pin=8638250174862&hs=0>
When
torstai 15. tammi 2026 ⋅ 9ap – 10ap (Itä-Euroopan aika - Helsinki)
Guests
Jasurbek Ayupov<mailto:jasurbek.ayupov@skyinq.com> - organizer
yjkwonipk(a)gmail.com<mailto:yjkwonipk@gmail.com>
bth(a)mbdbiotech.com<mailto:bth@mbdbiotech.com>
Jake Kim<mailto:jake.kim@skyinq.com>
Ulla Lenkkeri<mailto:ulla.lenkkeri@skyinq.com>
Soyeh KIM<mailto:soyeh.kim@skyinq.com>
lauri.eklund(a)oulu.fi<mailto:lauri.eklund@oulu.fi>
View all guest info<https://calendar.google.com/calendar/event?action=VIEW&eid=M3E2aGtiaGVpYmhq…>
Reply for lauri.eklund(a)oulu.fi<mailto:lauri.eklund@oulu.fi>
Yes<https://calendar.google.com/calendar/event?action=RESPOND&eid=M3E2aGtiaGVpY…>
No<https://calendar.google.com/calendar/event?action=RESPOND&eid=M3E2aGtiaGVpY…>
Maybe<https://calendar.google.com/calendar/event?action=RESPOND&eid=M3E2aGtiaGVpY…>
More options<https://calendar.google.com/calendar/event?action=VIEW&eid=M3E2aGtiaGVpYmhq…>
Invitation from Google Calendar<https://calendar.google.com/calendar/>
You are receiving this email because you are an attendee on the event.
Forwarding this invitation could allow any recipient to send a response to the organizer, be added to the guest list, invite others regardless of their own invitation status, or modify your RSVP. Learn more<https://support.google.com/calendar/answer/37135#forwarding>